Kolon TissueGene

    OverviewSuggest Edit

    Kolon TissueGene is a company developing cell therapies to target various orthopedic diseases and degenerative disorders. Its main product is INVOSSA, a cell and gene therapy for osteoarthritis.
    TypePrivate
    Founded1999
    HQRockville, US
    Websitetissuegene.com

    Locations

    Kolon TissueGene is headquartered in
    Rockville, United States

    Location Map

    Latest Updates

    Employees (est.) (Jun 2020)36(+6%)
    Cybersecurity ratingAMore

    Kolon TissueGene Office Locations

    Kolon TissueGene has an office in Rockville
    Rockville, US (HQ)
    9713 Key W Ave #300
    Show all (1)

    Kolon TissueGene Financials and Metrics

    Summary Metrics

    Founding Date

    1999

    Kolon TissueGene Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    97/100

    SecurityScorecard logo

    Kolon TissueGene Online and Social Media Presence

    Embed Graph

    Kolon TissueGene Frequently Asked Questions

    • When was Kolon TissueGene founded?

      Kolon TissueGene was founded in 1999.

    • How many employees does Kolon TissueGene have?

      Kolon TissueGene has 36 employees.

    • Who are Kolon TissueGene competitors?

      Competitors of Kolon TissueGene include Dyadic International, Maijing Gene and Angiocrine Bioscience.

    • Where is Kolon TissueGene headquarters?

      Kolon TissueGene headquarters is located at 9713 Key W Ave #300, Rockville.

    • Where are Kolon TissueGene offices?

      Kolon TissueGene has an office in Rockville.

    • How many offices does Kolon TissueGene have?

      Kolon TissueGene has 1 office.